We developed and morphologically characterized a human genital mucosa explant model (endocervix and ectocervix/ vagina) to mimic genital herpes infections caused by herpes simplex virus types 1 (HSV-1) and 2 (HSV-2). Subsequent analysis of HSV entry receptor expression throughout the menstrual cycle in genital tissues was performed, and the evolution of HSV-1/-2 mucosal spread over time was assessed. Nectin-1 and -2 were expressed in all tissues during the entire menstrual cycle. Herpesvirus entry mediator expression was limited mainly to some connective tissue cells. Both HSV-1 and HSV-2 exhibited a plaque-wise mucosal spread across the basement membrane and induced prominent epithelial syncytia.
Human genital herpes is worldwide one of the most important sexually transmitted infections. The principal causative agent is herpes simplex virus type 2 (HSV-2); however, the frequency of primary genital herpes infections caused by herpes simplex virus type 1 (HSV-1) is increasing [1] . Additionally, genital herpes lesions promote the transmission of human immunodeficiency virus (HIV). HSV-2 has been shown to modulate the mucosal microenvironment, including the recruitment of submucosal dendritic cells, which might contribute to an increased susceptibility to HIV infection [1, 2] . No efficacious HSV vaccine is currently on the market, and the likelihood of one coming to market soon is low [3] .
Rodent models are considered to be the gold standard for genital herpes research [4, 5] . Although they play a robust role in elucidating aspects of primary genital mucosa infections, they clearly lack homology with humans. Potential species-specific differences in cellular mediators of infection and invasion impede extrapolation of results. For example, several entry mediators have been described for HSV, including nectins (nectin-1 and nectin-2), herpesvirus entry mediator (HVEM), and specific sites in heparan sulfate. Although nectin homologues in mice resemble the human forms, mouse nectin-2 is not functional as an entry receptor for HSV-1 and HSV-2, whereas human nectin-2 clearly mediates entry of HSV-2 and certain HSV-1 recombinants [6] . Interestingly, until now, information on the presence and distribution of entry mediators and their potential in vivo role within the genital tract is scarce.
In this study, we optimized a human genital mucosa explant model in a way similar to that of a previously optimized bovine genital mucosa explant model [7] . Next, we analyzed the expression patterns of different herpes virus entry receptors, including nectin-1, nectin-2, and HVEM, in the endocervix and ectocervix/vagina throughout the menstrual cycle. Finally, we modeled the mucosal behavior of HSV-1 and HSV-2 in the genital mucosa by inoculating genital organ cultures and compared the HSV-1 and HSV-2 replication characteristics within the same patients.
PATIENTS AND METHODS
Specimens of healthy genital mucosa were gathered from 15 women undergoing a routine hysterectomy (Ghent University Hospital). In addition, serum was collected for determination of progesterone/estradiol levels and of HSV-specific neutralizing antibody titers by means of the complement-dependent seroneutralization test. The latter test does not allow discrimination between antibodies raised against HSV-1 and those raised against HSV-2. All persons provided written informed consent, and the ethics committee of the Ghent University Hospital approved the study (EC/2010/152). Different patients at various stages of the menstrual cycle were included for all experiments (Supplementary Table 1) . A more detailed description of the in vitro model, the applied techniques for evaluating tissue viability/morphology, and the inoculation method is provided in the Supplementary Materials and is similar to that reported elsewhere [7] .
The strains used in this study for inoculation of human genital mucosa explants were HSV-1 strain F (ATCC VR-733) and HSV-2 strain MS (ATCC VR-540), cultured on Vero cells (ATCC CCL-81). HSV-inoculated explants were collected at 0 hours and 48 hours after inoculation.
Evaluation of relative HSV entry receptor expression was performed on non-cultured, non-inoculated tissues (time point 0 hour) of 10 different patients at various menstrual cycle stages by means of immunofluorescence stainings. Cryosections of 10 µm were fixed in 100% methanol at −20°C for 20 minutes. We used mouse monoclonal antibodies CK41, L14, and D-5 (Santa Cruz Biotechnology) directed against nectin-1 (diluted 1:50 in phosphate-buffered saline [PBS]), nectin-2 (diluted 1:20 in PBS), and HVEM (diluted 1:50 in PBS), respectively. After 1 hour of incubation at 37°C, samples were thoroughly washed and incubated at 37°C for 1 hour with goat antimouse fluorescein isothiocyanate (FITC).
From all HSV-inoculated explants, 20-µm-thick consecutive cryosections were made and fixed in methanol. First, to visualize the basement membrane (BM) barrier, we used primary goat anti-collagen IV antibodies (Southern Biotech; diluted 1:50 in PBS), secondary biotinylated rabbit anti-goat antibodies (Sigma; diluted 1:100 in PBS), and tertiary streptavidin-Texas red antibodies (Molecular Probes; diluted 1:50 in PBS). Second, HSV-1 or HSV-2 antigens were stained with primary mouse monoclonal antibodies against HSV-1 glycoprotein D (diluted 1:100 in PBS and 10% normal goat serum [NGS]) or HSV-2 glycoprotein B (gB; diluted 1:50 in PBS and 10% NGS; Santa Cruz Biotechnology), respectively, followed by secondary FITC-labeled goat anti-mouse antibodies (Molecular Probes; diluted 1:100 in PBS and 10% NGS). Next, measurements of average HSV-1/-2 plaque latitude and plaque penetration underneath the BM were performed at 0 hours and 48 hours after inoculation.
SPSS software was used to evaluate the variance by means of 1-way analysis of variance, the post-hoc Bonferroni correction, and the Tukey honest significant difference test. The results are given as means + SDs of different (≥3) independent experiments. Results with P values of ≤ .05 were considered statistically significant.
RESULTS
Serum reproductive hormone levels and HSV-specific neutralizing antibody titers of patients are given in Supplementary  Table 1 . No significant changes were observed in the occurrence of apoptosis during the in vitro cultivation of endocervical and ectocervical mucosa for up to 96 hours (ie, the end of the experiment; Supplementary Figure 1) . Light microscopy showed endocervical mucosa to be lined by a simple columnar epithelium interspersed by mucus-producing cells. Ectocervical epithelium consisted of a nonkeratinized stratified squamous epithelium similar to the vaginal epithelium. For all tissues, no significant changes in epithelial thickness could be observed because of in vitro culture (Supplementary Figure 1) . Analysis of the composition of the connective tissue revealed no significant differences in the percentage of nuclei or collagen due to cultivation. The lamina reticularis thickness, as part of the BM, could be maintained throughout tissue culture (Supplementary Figure 1 ). Transmission electron microscopy revealed that epithelial integrity and BM continuity (lamina densa) were conserved at all time points for both endocervical and ectocervical tissues.
Regardless of the phase of the menstrual cycle, the expression pattern and localization of all HSV entry receptors was consistent for the endocervix and ectocervix/vagina (Figure 1 ). In general, for all patients, both nectins were clearly more abundantly expressed in the endocervix, compared with the ectocervix/vagina. At all times, nectin-2 antibody staining was found to be more intense than antibody staining for nectin-1 in the genital tract. In endocervical epithelium, nectins were highly present on the luminal side of the cell and, thus, the apicolateral region. In ectocervical/vaginal epithelium, nectin-1 and -2 expression was most intense in the stratum spinosum and minimal in the stratum basale. Loss of nectin-1 and -2 expression was seen within the superficial layers of the ectocervix/vagina. Consequently, whenever epithelial thickness shrivels, nectin expression was located closer to the luminal side, as was observed in postmenopausal women and women in the luteal phase of the menstrual cycle. The majority of HVEM-expressing cells were observed in the lamina propria and deeper connective tissue. Scarcely distributed single cells resident within the epithelium were also found to be HVEM positive. Nevertheless, the majority of the endocervical and ectocervical epithelium clearly did not express HVEM.
HSV-1 and HSV-2 both replicated plaque-wise in endocervical and ectocervical mucosa of all included patients (Figure 2) . In ectocervical mucosa, HSV plaques were often localized at places of slight abrasion within the superficial layers. All HSV-induced ectocervical plaques were situated within the stratum spinosum, and some extended to the stratum basale. Infection within the stratum superficialis was never observed. Interestingly, large multinucleated giant cells were observed in HSV epithelial plaques in the ectocervix. Starting 48 hours after inoculation, few (<10%) ectocervical and endocervical epithelial viral plaques crossed the BM, albeit in a localized manner.
DISCUSSION
The mucosal behavior of genital herpes infection caused by HSV-1 and HSV-2 at the level of the mucosa within human tissues has been poorly documented until now. Little information is known about the presence of herpesvirus entry factors in the genital tract. One in vivo comparative study reported that human nectin-1 expression and localization remains identical at different stages of the menstrual cycle, whereas in mice striking differences in expression levels were seen [4] . We observed similar results when analyzing nectin-1 expression in human ectocervix/vagina for all menstrual cycle stages and additionally found the localization of nectin-2 to be quite similar to that of nectin-1 within the ectocervix/vagina. In the endocervix, the expression of nectin-1/-2 was found on the apicolateral side of the cells at all times. Our study confirms the preferential lateral localization of nectins in adherens junctions in polarized human endocervical epithelium, compared with nonpolarized ectocervical epithelium [8] . HVEM expression was found to be limited to multiple cells in the connective tissue and to some cells residing in the epithelium. Assumedly, the HVEM-expressing cells we observed are resident immune cells [8, 9] . It is known that HVEM, as a member of the tumor necrosis factor receptor family, is broadly expressed in hematopoietic cells, of which some constitutively express HVEM [10] .
We detected several syncytia or multinucleated giant cells within HSV-induced epithelial plaques. These syncytia were not observed previously when stuyding the dissemination of several animal alphaherpesviruses in mucosal tissues [7, 11] . Cell-cell fusion is a key process in the formation of syncytia. A main player in herpesvirus-induced membrane fusion is gB, a type III fusion protein. Interestingly, there may be some variability among herpesviruses in how gB is processed and activated. In addition, fusion triggering is regulated by other viral glycoproteins and their receptors, as well. These slight differences in gB-mediated fusion across herpesviruses may have in vivo implications and might explain the different observed phenotypes [12] . Alternatively, residing macrophages in the epithelium have the ability to undergo cell-cell fusion upon specific stimuli, resulting in syncytia formation. Hence, these structures may play a beneficial role in the elimination of pathogens and foreign particles. However, they may also be deleterious to the Figure 1 . Herpes simplex virus (HSV) entry receptor expression in human endocervical and ectocervical tissues. By means of immunofluorescence staining, the different HSV entry receptors were marked with fluorescein isothiocyanate (green) and cell nuclei with Hoechst (blue). Nectin-1 (A) and nectin-2 (C) expression is mainly localized in the stratum spinosum of the ectocervix at all phases of the menstrual cycle. In the endocervix a strong nectin-1 (B) and nectin-2 (D) expression can be observed on mainly the apicolateral sides of the cell membrane throughout the menstrual cycle. Images A-D are taken from tissues in the luteal phase of the menstrual cycle but are representative for all different phases during the menstrual cycle. E, Especially during the follicular phase of the menstrual cycle, the ectocervical stratum superficial consists of multiple layers (double-headed arrow) of non-nectin-expressing cells (dashed line marks the entire epithelium). F, Herpesvirus entry mediator expression was observed on cells located in the lamina propria (arrows) and scarcely on individual cells residing in the epithelium (dashed arrow), regardless of the menstrual cycle stage.
host, by promoting tissue destruction and facilitating microbial survival [13] . Suggestively, HSV might be subverting this mechanism of macrophages within plaques to promote prolonged persistence in the epithelium as an immune evasion strategy [13] .
In both ectocervical and endocervical tissues, HSV was found to disseminate well. Our observations, showing the absence of HSV entry receptors in the superficial layers of the ectocervix/ vagina, suggests HSV's need for epithelial microlesions to initiate invasion in the ectocervix/vagina. In our study, ectocervical HSV plaques were only found within the stratum spinosum and basale and extended by analogy with their entry receptors. In addition, we often observed HSV plaques at places of slight abrasion/scarification. The abundant presence of nectins in the endocervix renders this anatomical site a potential target for efficient invasion. Exposure of the endocervical epithelium to the ectocervical/vaginal cavity (cervical ectopy) because of hormonal influences is a common event in life. Elsewhere, it was reported that this site is highly susceptible to HIV infection and other sexually transmitted infections [14] . Hence, cervical ectopy might be highly prone to herpesvirus infections. In line with previous findings, our results suggest no association of HSV susceptibility and replication with menstrual cycle phase or with physiological estradiol/progesterone levels [15] . However, because of the limited amount of samples used in this study, this must be carefully considered.
At 48 hours after inoculation, proof of HSV breaching through the BM barrier was observed in a minority of endocervical and ectocervical plaques. This observation reflects what is seen in vivo. Some studies show that primary HSV infections of the genital tract in humans are often followed by a clear HSV viremia [5] . Because we only analyzed samples taken 48 hours after inoculation, we cannot exclude that, at later time points after inoculation, the amount of BM-penetrating plaques and/ or the plaque penetration depth may increase. Nevertheless, the observation that some plaques penetrate the BM suggests that HSV is able to reach blood vessels and spread within the host by a yet unknown mechanism.
In summary, we are the first to describe the distribution of nectin-1, nectin-2, and HVEM within the lower female genital tract, including the endocervix and ectocervix/vagina, during different phases of the normal menstrual cycle and to point out the anatomical relevance of nectins as entry receptors for HSV. In addition, we report the first comparison of the mucosal dissemination of both human HSV types within endocervical and ectocervical/vaginal mucosa derived from the same patients. Despite their different tropism, these viruses are able to replicate and spread to a similar extent within the genital mucosa and to penetrate the BM. This study highlights the observed trend of increasing HSV-1 genital infections seen in the field [1] and stresses the importance of combating HSV infection as a means to aid anti-HIV therapy.
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